Baicalin and kaempferol alleviates cuprizone-induced demyelination and microglial activation by inhibiting the STAT3 and NF-κB signaling pathways
International Immunopharmacology · 2025-05 · 154 · 114592
DOI: 10.1016/j.intimp.2025.114592 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-05. Verfasst von Liming Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Research and Development on the Whole Industry Chain for Yu-Yao of Henan Province, Henan University of Chinese Med…. Hauptthemen laut MEDLINE: Flavonoids, Microglia, STAT3 Transcription Factor, Kaempferols. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Henan Provincial Science and Technology Research Project, Department of Science and Technology of Henan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Microglia-mediated neuroinflammation plays a critical role in myelin loss in multiple sclerosis (MS). Baicalin (BAI) and kaempferol (KAE) are known for their potent anti-inflammatory properties; however, their potential to alleviate demyelination and treat MS has rarely been rarely investigated. METHODS: Demyelination was induced in mice using cuprizone (CPZ), and behavioral assessments were conducted to evaluate motor function recovery following treatment with BAI and KAE. Myelin loss was assessed using transmission electron microscopy. Immunofluorescence and Western blot analyses were employed to assess microglial activation and neuroinflammatory responses. Moreover, network pharmacology, molecular docking, and Drug Affinity Responsive Target Stability (DARTS) were utilized to identify molecular targets involved in the therapeutic effects of BAI and KAE. RESULTS: Both BAI and KAE significantly improved motor function and mitigated myelin loss in CPZ-treated mice. These compounds effectively inhibited CPZ-induced microglial activation and attenuated secretion of pro-inflammatory cytokines. Network pharmacology identified the STAT3 and NF-κB as potential targets of BAI and KAE. In vivo and in vitro validation further confirmed that both compounds significantly suppressed the phosphorylation of STAT3 and NF-κB p65 proteins. CONCLUSION: Our findings suggest that BAI and KAE alleviate CPZ-induced demyelination by inhibiting STAT3 and NF-κB signaling pathways, thereby reduced microglial activation and alleviation of neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center of Research and Development on the Whole Industry Chain for Yu-Yao of Henan Province, Henan University of Chinese Medicine, Zhengzhou 450046, PR China; College of Pharmacy, Henan Universi…
- College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, PR China.
- Collaborative Innovation Center of Research and Development on the Whole Industry Chain for Yu-Yao of Henan Province, Henan University of Chinese Medicine, Zhengzhou 450046, PR China; Academy of Chinese Medical Sciences…
Förderung
- Henan Provincial Science and Technology Research Project
- Department of Science and Technology of Henan Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, L., Zhao, Y., Bu, J., Peng, S., Li, Y., Su, P., & Li, Y. (2025). Baicalin and kaempferol alleviates cuprizone-induced demyelination and microglial activation by inhibiting the STAT3 and NF-κB signaling pathways. International Immunopharmacology, 154, 114592. https://doi.org/10.1016/j.intimp.2025.114592
Vancouver
Liu L, Zhao Y, Bu J, Peng S, Li Y, Su P, et al. Baicalin and kaempferol alleviates cuprizone-induced demyelination and microglial activation by inhibiting the STAT3 and NF-κB signaling pathways. International Immunopharmacology. 2025;154:114592. doi:10.1016/j.intimp.2025.114592
BibTeX
@article{Liu2025,
author = {Liu, Liming and Zhao, Yufang and Bu, Jingjing and Peng, Shuaijun and Li, Yuyao and Su, Pan and Li, Yucheng},
title = {Baicalin and kaempferol alleviates cuprizone-induced demyelination and microglial activation by inhibiting the STAT3 and NF-κB signaling pathways},
journal = {International Immunopharmacology},
year = {2025},
volume = {154},
pages = {114592},
doi = {10.1016/j.intimp.2025.114592}
}
EUVIMED